GONZALEZ-RIVAS, J. P., J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA, J. R. MEDINA-INOJOSA, Sarka KUNZOVA, R. NIETO-MARTINEZ, Jan BROZ, L. BUSETTO, G. A. M. NETO, F. LOPEZ-JIMENEZ, Jana URBANOVA and G. B. STOKIN. Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study. OBESITY SCIENCE & PRACTICE. HOBOKEN: WILEY, 2021, vol. 7, No 5, p. 535-544. ISSN 2055-2238. Available from: https://dx.doi.org/10.1002/osp4.496.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study
Authors GONZALEZ-RIVAS, J. P. (guarantor), J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA (804 Ukraine, belonging to the institution), J. R. MEDINA-INOJOSA, Sarka KUNZOVA (203 Czech Republic), R. NIETO-MARTINEZ, Jan BROZ (203 Czech Republic), L. BUSETTO, G. A. M. NETO, F. LOPEZ-JIMENEZ, Jana URBANOVA (203 Czech Republic) and G. B. STOKIN.
Edition OBESITY SCIENCE & PRACTICE, HOBOKEN, WILEY, 2021, 2055-2238.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30202 Endocrinology and metabolism
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/21:00121638
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/osp4.496
UT WoS 000647238400001
Keywords in English adiposity; cardiovascular disease; epidemiology; obesity; overweight
Tags 14110525, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 7/12/2021 13:01.
Abstract
Aims/Hypothesis The need for understanding obesity as a chronic disease, its stigmatization, and the lack of actionability related to it demands a new approach. The adiposity-based chronic disease (ABCD) model is based on adiposity amount, distribution, and function, with a three stage complication-centric rather than a body mass index (BMI)-centric approach. The prevalence rates and associated risk factors are presented. Methods In total, 2159 participants were randomly selected from Czechia. ABCD was established as BMI >= 25 kg/m(2) or high body fat percent, or abdominal obesity and then categorized by their adiposity-based complications: Stage 0: none; Stage 1: mild/moderate; Stage 2: severe. Results ABCD prevalence was 62.8%. Stage 0 was 2.3%; Stage 1 was 31.4%; Stage 2 was 29.1%. Comparing with other classifiers, participants in Stage 2 were more likely to have diabetes, hypertension, and metabolic syndrome than those with overweight, obesity, abdominal obesity, and increased fat mass. ABCD showed the highest sensitivity and specificity to detect participants with peripheral artery disease, increased intima media, and vascular disease. Conclusion/Interpretation The ABCD model provides a more sensitive approach that facilitates the early detection and stratification of participants at risk compared to traditional classifiers.
PrintDisplayed: 26/7/2024 23:30